Physician profile
Timothy E Spencer
NPI 1053375758
$543,172.97
in general payments reported to CMS, 2019-2025
37 companies · $21K in 2025
The $21K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96K · 2020: $26K · 2021: $32K · 2022: $166K · 2023: $153K · 2024: $49K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $222K · Food and Beverage: $1,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $221,788.46 |
| Food and Beverage | $1,485.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osseus Fusion Systems, LLC | $469,427.69 | 2019-2025 | |
| Ikon Spine LLC | $60,456.60 | 2019-2024 | Itpc, Cervical and Lumbar Interbody Fusion Devices |
| Amendia, INC. | $10,359.90 | 2019 | |
| Radius Health, INC. | $572.37 | 2019-2025 | Tymlos |
| Amgen INC. | $406.42 | 2019-2025 | Evenity, Prolia |
| Lilly USA, LLC | $192.64 | 2021-2023 | Reyvow, Emgality |
| Nevro Corp. | $171.39 | 2023-2024 | Senza |
| 7d Surgical INC. | $171.16 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $158.83 | 2022-2023 | Seglentis |
| Pfizer INC. | $144.97 | 2020-2025 | |
| Orthofix Medical, INC. | $124.92 | 2021-2024 | Spinal-Stim, Spinal-Stim |
| Abbott Laboratories | $114.94 | 2019-2022 | |
| Cerapedics INC. | $98.99 | 2022 | |
| Providence Medical Technology, INC. | $89.15 | 2019-2020 | |
| Ethicon US, LLC | $86.86 | 2020-2025 | Stratafix, Surgicel Nu-Knit, Ethicon |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $69.89 | 2025 | Senza |
| Si-Bone, INC. | $60.93 | 2019-2025 | |
| Augmedics INC. | $46.40 | 2021-2023 | Xvision |
| Sanara Medtech INC. | $37.15 | 2023-2024 | Celleraterx, Biasurge |
| Nalu Medical, INC. | $34.59 | 2021 | |
| Stryker Corporation | $32.19 | 2021 | |
| Daiichi Sankyo INC. | $30.78 | 2019 | |
| Lemaitre Vascular, INC. | $28.92 | 2023 | Anastoclip Gc 8cm (Medium) |
| Aesculap, INC. | $26.05 | 2025 | Elan 4 |
| Pacira Pharmaceuticals Incorporated | $21.66 | 2025 | Exparel |
| Ascendis Pharma Endocrinology INC | $21.42 | 2025 | Yorvipath |
| Surgalign Spine Technologies, INC. | $21.17 | 2019 | |
| Innovasis INC | $19.54 | 2022 | |
| Djo, LLC | $18.60 | 2023 | Cmf |
| Kci USA, INC. | $18.35 | 2023 | Prevena |
| Boston Scientific Corporation | $17.97 | 2019 | |
| Alvogen INC | $17.47 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $16.31 | 2022 | |
| Heron Therapeutics, INC. | $15.88 | 2024 | Zynrelef |
| Spinal Simplicity, LLC | $15.02 | 2024 | Ha Minuteman G3-R |
| Baxter Healthcare | $14.36 | 2019 | |
| Medtronic USA, INC. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.